Prosecution Insights
Last updated: August 15, 2026

Paul Scherrer Institut

6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
5
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (50%)
2
Medium (33%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (17%)
§112 only1 (17%)
Double-patenting + other1 (17%)
Multi-statute (no §101)3 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MCAVOY, ELLEN M 1 72.9% +8.5%
LIEB, JEANETTE M 1 79.9% +17.2%
TAYLOR, JORDAN W 1 64.0% +39.0%
ROGERS, JAMES WILLIAM 1 46.2% +22.1%
STAVROU, CONSTANTINA E 1 44.2% +36.3%
DICKINSON, PAUL W 1 62.8% +9.9%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18719462 METHOD AND PLANT FOR OBTAINING A MAIN PRODUCT STREAM FOR THE PRODUCTION OF TRANSPORT FUEL MCAVOY, ELLEN M
18566216 Isolated Metal Species in Metal-Zeolite Catalytic Material for Low Temperature SCR of NOx with NH3 TAYLOR, JORDAN W
18552124 [161Tb]-BASED RADIOPEPTIDES ROGERS, JAMES WILLIAM

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17918981 METHOD FOR FIBROBLAST REJUVENATION BY MECHANICAL REPROGRAMMING AND REDIFFERENTIATION STAVROU, CONSTANTINA E 14d
18426675 SITE-SPECIFIC CONJUGATION TO ANTIBODY LYSINE RESIDUES WITH SOLID-PHASE IMMOBILIZED MICROBIAL TRANSGLUTAMINASE MTG AND MTG IN SOLUTION LIEB, JEANETTE M
18566216 Isolated Metal Species in Metal-Zeolite Catalytic Material for Low Temperature SCR of NOx with NH3 TAYLOR, JORDAN W
18552124 [161Tb]-BASED RADIOPEPTIDES ROGERS, JAMES WILLIAM

Top Art Units

Art UnitApps
1618 2
1771 1
1654 1
1632 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18719462 METHOD AND PLANT FOR OBTAINING A MAIN PRODUCT STREAM FOR THE PRODUCTION OF TRANSPORT FUEL MCAVOY, ELLEN M 1771 §103§112 Non-Final OA Pending Jun 13, 2024
18426675 SITE-SPECIFIC CONJUGATION TO ANTIBODY LYSINE RESIDUES WITH SOLID-PHASE IMMOBILIZED MICROBIAL TRANSGLUTAMINASE MTG AND MTG IN SOLUTION LIEB, JEANETTE M 1654 §112DP Non-Final OA Pending Jan 30, 2024
18566216 Isolated Metal Species in Metal-Zeolite Catalytic Material for Low Temperature SCR of NOx with NH3 TAYLOR, JORDAN W §102§103§112 Non-Final OA Pending Dec 01, 2023
18552124 [161Tb]-BASED RADIOPEPTIDES ROGERS, JAMES WILLIAM 1618 §102§103 Non-Final OA Pending Sep 22, 2023
17918981 METHOD FOR FIBROBLAST REJUVENATION BY MECHANICAL REPROGRAMMING AND REDIFFERENTIATION STAVROU, CONSTANTINA E 1632 §103 Final Rejection 14d Pending Oct 14, 2022
17298321 NOVEL TUMOR ANTIGEN BINDING AGENTS AND USES THEREOF DICKINSON, PAUL W 1618 §112 Non-Final OA Pending May 28, 2021

Managing Paul Scherrer Institut's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month